Australia’s regulator of drugs and medical devices is planning to use artificial intelligence to speed up testing of new medicines already signed off in similar nations, as it comes to grips with shorter drug development lead times.
The proposal, which would bring the Therapeutic Goods Administration (TGA) into line with its sister regulator in the United Kingdom, could shave months off assessment wait times that can sometimes take up to a year to complete.
It is one of several proposals involving AI that regulators have pitched in responses to a call from the federal government ahead of the productivity roundtable to find quick wins to cut red tape.
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.
Do you know more? Contact James Riley via Email.